Ibex Investors LLC Axogen, Inc. Transaction History

Ibex Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $280,415 - $407,242	-7,757 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$24.4 - $40.25 $34,574 - $57,034	-1,417 Reduced 15.45%	7,757 $283,000
Q4 2017 Feb 27, 2019	SELL	$18.5 - $28.6 $2,183 - $3,374	-118 Reduced 1.27%	9,174 $263,000
Q4 2017 Nov 21, 2018	BUY	$18.5 - $28.6 $2,183 - $3,374	118 Added 1.29%	9,292 $263,000
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $169,719 - $262,376	9,174	9,174 $259,000

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $534M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Ibex Investors LLC with notifications on news.